Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
Items 401–500 of 816
Ojalill, M., Rappu, P., Siljamäki, E., Taimen, P., Boström, P. J., & Heino, J. (2018) · The Prostate · doi:10.1002/pros.23503 · Cited by 14
“The critical uncertainties related to specificity of antibodies [19] especially complicates the analyses focused on the expression of protein with complex molecular composition, such as”
BackgroundThe reliability of the isotropic fractionator method for counting total cells and neurons
Neves, K., Guimarães, D. M., Rayêe, D., Valério‐Gomes, B., Iack, P. M., Lent, R., & Mota, B. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108392 · Cited by 16
Recommendations for description and validation of antibodies for research use
Rižner, T. L., Sasano, H., Choi, M. H., Odermatt, A., & Adamski, J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.11.021 · Cited by 14
“This editorial tackles part of an immense current problem in science, the irreproducibility of data [23].”
BackgroundOn Methods for the Measurement of the Apelin Receptor Ligand Apelin
Janssens, P., de Loor, H., Decuypere, J.-P., Vennekens, R., Llorens‐Cortés, C., Mekahli, D., & Bammens, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-11835-z · Cited by 13
Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry–based de novo sequencing
Peng, W., Giesbers, K. C. A. P., Šiborová, M., Beugelink, J. W., Pronker, M. F., Schulte, D., Hilkens, J., Janssen, B. J. C., Strijbis, K., & Snijder, J. (2024) · Life Science Alliance · doi:10.26508/lsa.202302366 · Cited by 13
“Poorly de fi ned (monoclonal) antibody products have notoriously been a challenge to reproducibility in life science research, and the present work shows that MS-based sequencing can offer helpful improvements in this regard (37, 38).”
BackgroundMahatnirunkul, T., Tomlinson, D. C., McPherson, M. J., & Millner, P. A. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.131709 · Cited by 13
“There was a report on this issue in 2015 (Baker, 2015; Bradbury and Plückthun, 2015) suggesting that antibody variation is a major cause of reproducibility problems in life sciences research because of batch-to-batch variability and poor characterisation.”
BackgroundOmilian, A. R., Zirpoli, G., Cheng, T. D., Yao, S., Stein, L. C., Davis, W., Head, K. L., Nair, P., Khoury, T., Ambrosone, C. B., et al. (2019) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000756 · Cited by 13
In Silico Discovery and Validation of Neuropeptide-Y-Binding Peptides for Sensors
Xiao, X., Kuang, Z., Burke, B. J., Chushak, Y. G., Farmer, B. L., Mirau, P. A., Naik, R. R., & Hall, C. K. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b09439 · Cited by 15
Zucchelli, P., Horak, G., & Skinner, N. (2020) · SLAS TECHNOLOGY · doi:10.1177/2472630320971218 · Cited by 13
“There has been considerable debate about the causes, although common factors include basic flaws in experimental practice, 4,12,13 variability in antibody-based methods and assays, 14 and article retractions reported in PubMed.”
BackgroundSchröder, S. K., Tag, C. G., Kessel, J. C., Antonson, P., & Weiskirchen, R. (2022) · Biomedicines · doi:10.3390/biomedicines10123100 · Cited by 21
Clinical Proteomics for Solid Organ Tissues
Phipps, W. S., Kilgore, M., Kennedy, J. J., Whiteaker, J. R., Hoofnagle, A. N., & Paulovich, A. G. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100648 · Cited by 13
“These tools helped fuel a reproducibility crisis due to the challenges of cross-reactivity and batch-to-batch variability (61).”
BackgroundYang, Y., Guo, M., Guo, S., Tian, J., & Gu, D. (2024) · Bioresource Technology · doi:10.1016/j.biortech.2024.130894 · Cited by 13
Zheng, S., Yang, C., Liu, T., Liu, Q., Dai, F., Sheyhidin, I., & Lu, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4610-9 · Cited by 13
Echeazarra, L., del Caño, G. G., Barrondo, S., González‐Burguera, I., Saumell-Esnaola, M., Aretxabala, X., de Jesús, M. L., Roman, L. B., Mato, S., Ledent, C. A., et al. (2021) · Histochemistry and Cell Biology · doi:10.1007/s00418-021-02025-5 · Cited by 14
“2012; Baker 2015), and serious doubts had been raised about the usefulness of a variety of anti-GPCR antibodies (O’Connell et al.”
BackgroundResponse: Commentary: Analysis of SUMO1-conjugation at synapses
Daniel, J. A., Cooper, B. H., Palvimo, J. J., Zhang, F., Brose, N., & Tirard, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00117 · Cited by 13
“Large-scale studies indicate that only ∼50% of commercially available antibodies can be used to reliably assess protein distribution in tissue (Baker, 2015).”
Manuel, S. L., Johnson, B. W., Frevert, C. W., & Duncan, F. E. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy094 · Cited by 14
Shaker, S., Li, J., Wan, S., Xuan, H., Long, J., Cao, H., Wei, T., Liu, Q., Xu, D., Benner, S. A., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf072 · Cited by 12
Young, L. N., Sherrard, A., Zhou, H., Shaikh, F., Hutchings, J., Riggi, M., Narasimhan, M., Flaherty, W. A., Bennett, E. J., Rosen, M. K., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02928-4 · Cited by 12
“Moreover, a growing consensus argues that poorly vetted commercial antibodies contribute to the reproducibility crisis in basic science 10,11 .”
Selection and characterization of FcεRI phospho-ITAM specific antibodies
Velappan, N., Mahajan, A., Naranjo, L. A., Velappan, P., Andrews, N., Tiee, N., Chakraborti, S., Hemez, C. F., Gaiotto, T., Wilson, B. S., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1632113 · Cited by 13
Heid, H., Zimbelmann, R., Dörflinger, Y., & Rickelt, S. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03152-1 · Cited by 13
“In recent years, false findings by abs are spread all over the field and the specificity of abs became a matter of intensive debate (Baker 2015).”
BackgroundChiriboga, L. A., Callis, G. M., Wang, Y., & Chlipala, E. A. (2022) · Journal of Histotechnology · doi:10.1080/01478885.2022.2134022 · Cited by 14
Guo, Z., Zhang, Q., Xing, R., & Liu, Z. (2023) · Chemical Communications · doi:10.1039/d2cc06550a · Cited by 13
Khaled, Y. S., Khot, M. I., Aiyappa‐Maudsley, R., Maisey, T. I., Pramanik, A., Tiernan, J. P., Lintern, N., Al-Enezi, E., Shamsuddin, S. H., Tomlinson, D. C., et al. (2023) · Nanoscale · doi:10.1039/d3nr04118b · Cited by 13
Exploring affinity chromatography in proteomics: A comprehensive review
Chamrád, I., Simerský, R., Lenobel, R., & Novák, O. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342513 · Cited by 15
A novel immunoassay for quantitative drug abuse screening in serum
Schumacher, S., & Seitz, H. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.06.004 · Cited by 14
The identification of a novel antibody for CD133 using human antibody phage display
Glumac, P. M., Forster, C. L., Zhou, H., Murugan, P. J., Gupta, S., & LeBeau, A. M. (2018) · The Prostate · doi:10.1002/pros.23656 · Cited by 12
“Recent studies have suggested that less than a quarter of all commercially available antibodies actually bind to their target antigen or work for their intended application.(23,24) Hybridoma-derived antibodies often cannot distinguish between highly homologous members of the same protein family or proteins with signif…”
BackgroundGrant, M. K. O., Shapiro, S. L., Ashe, K., Liu, P., & Zahs, K. (2019) · Biological Procedures Online · doi:10.1186/s12575-019-0095-z · Cited by 13
Selection and optimization of enzyme reporters for chemical cytometry
Proctor, A., Wang, Q., Lawrence, D. S., & Allbritton, N. L. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.02.023 · Cited by 15
“(Baker, 2015; Bougen-Zhukov et al., 2017; Su et al., 2017) Protein activity in single cells can be measured with energy transfer probes or fluorescent substrates, Methods Enzymol.”
BackgroundZhao, W., Huang, A., Yan, Z., Bie, Z., & Chen, Y. (2020) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2020.118258 · Cited by 12
CD11d is a novel antigen on chicken leukocytes
Deeg, C. A., Degroote, R. L., Giese, I.-M., Hirmer, S., Amann, B., Weigand, M., Wiedemann, C., & Hauck, S. M. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103876 · Cited by 12
Quality of histone modification antibodies undermines chromatin biology research
Kungulovski, G., & Jeltsch, A. (2015) · F1000Research · doi:10.12688/f1000research.7265.1 · Cited by 12
PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro
Cui, W., Zheng, S., Liu, Z., Wang, W., Cai, Y., Bi, R., Cao, B., & Zhou, X. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s129970 · Cited by 12
“Second, the specificity of the primary antibodies 21 used and the selection of cutoff value 22 in the scoring of IHC could also influence or even bias the final results.”
Byström, S., Fredolini, C., Edqvist, P.-H. D., Nyaiesh, E.-N., Drobin, K., Uhlén, M., Bergqvist, M., Pontén, F., & Schwenk, J. M. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.03.002 · Cited by 13
Validation of Tau Antibodies for Use in Western Blotting and ImmunohistochemistryPreprint
Ellis, M. J., Lekka, C., Tulmin, H., O'Brien, D. P., Dhayal, S., Zeissler, M., Knudsen, J. G., Kessler, B. M., Morgan, N. G., Todd, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.13.536711 · Cited by 14
A strong case for third-party testing
Lund‐Johansen, F. (2023) · eLife · doi:10.7554/elife.93329 · Cited by 13
Cheng, Y., Kim, M., Chen, Y., & Zhao, Y. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217574 · Cited by 11
Expression of the foraging gene in adult Drosophila melanogaster
Allen, A. M., & Sokolowski, M. B. (2021) · Journal of Neurogenetics · doi:10.1080/01677063.2021.1941946 · Cited by 16
“The context specificity of the utility of antibodies is a common problem (Baker, 2015).”
BackgroundYang, H., Qi, M., He, Q., Hwang, S. H., Yang, J., McCoy, M., Morisseau, C. H. P., Zhao, S., & Hammock, B. D. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.05.006 · Cited by 11
“However, industry and academia have been confronted with reproducibility issues of antibodies due to limited supply and large lot-tolot variability of polyclonal antibodies (pAb) or the tendency of monoclonal antibodies (mAb) hybridoma cells to die or be lost while recovering from storage [16].”
BackgroundLiu, X., Wang, C., Bai, Y., Wang, W., Han, Y., Cai, S., An, J., & Qu, G. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106615 · Cited by 11
Lee, K. H., & Zeng, H. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0454-z · Cited by 11
Authentication of experimental materials: A remedy for the reproducibility crisis?
Li, F., Hu, J., Xie, K., & He, T. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.07.001 · Cited by 11
“Two recent commentaries inNature and Nature Methods highlighted the importance of the quality control of antibody reagents and cell lines.(3,4) Both commentaries extensively discussed the existing quality problems associated with antibody reagents and cultured cell lines.”
BackgroundKollenstart, L., van der Horst, S. C., Vreeken, K., Janssen, G. M. C., Martino, F., Vlaming, H., van Veelen, P. A., van Leeuwen, F., & van Attikum, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-91359-0 · Cited by 13
Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research
Shoemaker, R. L., Larsen, R. J., & Larsen, P. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1426656 · Cited by 13
“Moreover, mAb biophysical stability varies in mammalian or monoclonal models, impacting its speci fi city and af fi nity, resulting in a loss of reliability in diagnostics and treatments (49, 50).”
BackgroundRecent progress in epitope-imprinted polymers for disease diagnosis and treatment
Xing, R., Chai, H., Liu, B., Wang, R., & Hu, S. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118423 · Cited by 10
RNA-in-situ-Hybridisierung: Technologie, Möglichkeiten und Anwendungsbereiche
Schipper, C., & Zielinski, D. (2020) · Der Pathologe · doi:10.1007/s00292-020-00839-z · Cited by 10
Zhao, M., Li, X., Li, X., Xie, H., Zhao, M., & Zhao, M. (2021) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2021.105036 · Cited by 10
Llobet, L., Bayona‐Bafaluy, M. P., Pacheu‐Grau, D., Torres-Pérez, E., Arbonés-Mainar, J. M., Navarro, M. Á., Gómez-Díaz, C., Montoya, J., López‐Gallardo, E., & Ruiz‐Pesini, E. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.026 · Cited by 10
“As we were particularly interested in the APOE protein, and it had been reported that the specificity of many antibodies to its target protein is very low [63], we verified its specificity by”
BackgroundPerzanowska, A., Fatalska, A., Wojtas, G., Lewandowicz, A., Michalak, A., Krasowski, G., Borchers, C. H., Dadlez, M., & Domański, D. (2018) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700084 · Cited by 11
Aptamer-facilitated mass cytometry
Mironov, G. G., Bouzekri, A., Watson, J. L., Loboda, O., Ornatsky, O., & Berezovski, M. V. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1011-0 · Cited by 10
“It was reported that only 11% of scientific findings of 53 Blandmark^ papers were found reproducible [6, 7].”
BackgroundReagent Validation to Facilitate Experimental Reproducibility
Williams, M. J. (2018) · Current Protocols in Pharmacology · doi:10.1002/cpph.40 · Cited by 11
“In theory, rABs would be less prone to cross reactivity and thus more selective in their actions and more appropriate for their selected application (Baker, 2015).”
BackgroundZhou, N., Xu, X., Li, X., Yao, W., He, X., Dong, Y., Liŭ, D., Hu, X., Lin, Y., Xie, Z., et al. (2021) · The Analyst · doi:10.1039/d1an01053k · Cited by 10
Zheng, S., Yang, C., Lu, M., Liu, Q., Liu, T., Dai, F., Gao, X., Sheyhidin, I., & Lu, X. (2016) · Human Pathology · doi:10.1016/j.humpath.2015.11.013 · Cited by 10
“Second, considering that the specificity and correctness of primary antibodies could lead to irreproducibility [31], all the primary antibodies should have been evaluated before being used.”
BackgroundThe NIH Protein Capture Reagents Program (PCRP): a standardized protein affinity reagent toolbox
Blackshaw, S., Venkataraman, A., Irizarry, J., Yang, K., Anderson, S., Campbell, E., Gatlin, C. L., Freeman, N. L., Basavappa, R., Stewart, R. R., et al. (2016) · Nature Methods · doi:10.1038/nmeth.4013 · Cited by 10
Castillo, D., Serantes, D. R., Melli, L. J., Ciocchini, A. E., Ugalde, J. E., Comerci, D. J., & Cassola, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182452 · Cited by 10
“In the last years, a "reproducibility crisis" phenomenon has emerged as a consequence of flaws in the reliability of antibodies [63, 64].”
BackgroundResearch antibodies: do not use them to stain your reputation
Delpire, E. J. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.zh0-7843-editorial.2015 · Cited by 10
“There are over 2 million antibodies on the market (1), but estimations are that only 100,000200,000 can be considered unique.”
BackgroundMultimerized epitope tags for high-sensitivity protein detection
Stowers, R. S. (2025) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkaf070 · Cited by 9
“Generation of protein-specific antibodies is cumbersome, time-consuming, not always successful, and may even lead to unrepro-ducible results (Rhodes and Trimmer 2006; Herkenham et al. 2011; Baker 2015; Bradbury and Pluckthun 2015 ).”
Cheng, Y., Nguyen, A., Nelson, W. C., Fujimoto, B. S., Zhao, M., & Chiu, D. T. (2025) · ACS Nano · doi:10.1021/acsnano.5c07028 · Cited by 9
Usman, M., Ashebir, S. E., Okey-Mbata, C., Yun, Y., & Kim, S. (2025) · Applied Sciences · doi:10.3390/app152111316 · Cited by 9
“The combination of genetic instability and epigenetic changes in extended cell cultures, along with the absence of standard operating procedures for organoid derivation, maintenance, and validation, creates obstacles for large-scale and reliable research [223–226].”
Translation and Post-translational Modifications in Protein Biosynthesis
Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_14 · Cited by 11
The determination of intact β-casein in milk products by biosensor immunoassay
Indyk, H. E., Gill, B. D., Wood, J. E., Chetikam, S., & Kobayashi, T. (2021) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2021.103946 · Cited by 9
Spatial Bias in Antibody Microarrays May Be an Underappreciated Source of Variability
Normandeau, F., Ng, A., Beaugrand, M., & Juncker, D. (2021) · ACS Sensors · doi:10.1021/acssensors.0c02613 · Cited by 10
Validation of antibodies: Lessons learned from the Common Fund Protein Capture Reagents Program
Roy, A. L., Wilder, E. L., & Anderson, J. M. (2021) · Science Advances · doi:10.1126/sciadv.abl7148 · Cited by 10
Misidentified biomedical resources: Journal guidelines are not a quick fix
Hepkema, W. M., Horbach, S. P. J. M., Hoek, J. M., & Halffman, W. (2021) · International Journal of Cancer · doi:10.1002/ijc.33882 · Cited by 10
“Undocumented test organism identity, unaccounted sources of genetic variability, or even microbiome variation, can threaten correct interpretation and use of research results, or even invalidate results, spread error, lead to irreproducible research and jeopardise translation to clinical applications.(7,8) A Nature su…”
BackgroundDisclosing quantitative RT‐PCR raw data during manuscript submission: a call for action
Untergasser, A., Hellemans, J., Pfaffl, M. W., Ruijter, J. M., van den Hoff, M. J. B., Dragomir, M. P., Adamóski, D., Dias, S. M. G., Reis, R. M., Ferracin, M., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13418 · Cited by 10
Developing a Toolbox of Antibodies Validated for Array Tomography-Based Imaging of Brain Synapses
Micheva, K. D., Gong, B., Collman, F., Weinberg, R. J., Smith, S. J., Trimmer, J. S., & Murray, K. D. (2023) · eNeuro · doi:10.1523/eneuro.0290-23.2023 · Cited by 9
“The lack of highly validated Abs for research is a widely-recognized problem (Begley and Ellis, 2012; Baker, 2015a,b) that has forced laboratories to employ extensive in-house Ab testing before their use (Bordeaux et al., 2010; Micheva et al., 2010a).”
BackgroundWei, D., Sun, J., Luo, Z., Zhang, G., Liu, Y., Zhang, H., Xie, Z., Gu, Z., & Tao, W. A. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04464 · Cited by 9
Penny, L., Main, S. C., Michino, S. D. D., & Bratman, S. V. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0004 · Cited by 10
Ready display of antigenic peptides in a protein ‘mimogen’
Vallée, M. R. J., Schombs, M. W., Balaban, Z. J., Colyer, J., & Davis, B. G. (2016) · Chemical Communications · doi:10.1039/c5cc08892e · Cited by 9
Quantifying the human proteome
Paulovich, A. G., & Whiteaker, J. R. (2016) · Nature Biotechnology · doi:10.1038/nbt.3695 · Cited by 12
Chloride channel 3 (CIC-3) predicts the tumor size in hepatocarcinoma
Cheng, W., Zheng, S., Li, L., Zhou, Q., Zhu, H., Hu, J. X., & Luo, H. (2019) · Acta Histochemica · doi:10.1016/j.acthis.2019.01.006 · Cited by 9
Li, H., Wu, C., Du, M., Chen, Y., Hou, X., Yang, Y., & Xie, K. (2021) · Molecular Breeding · doi:10.1007/s11032-021-01210-7 · Cited by 9
Chatzimichail, S., Supramaniam, P., & Salehi‐Reyhani, A. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c05177 · Cited by 9
Cordell, G. A. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112134 · Cited by 11
Li, P., Pang, J., Xu, S., He, H., Ma, Y., & Liu, Z. (2022) · Angewandte Chemie · doi:10.1002/ange.202113528 · Cited by 9
Wang, J., Jin, Y., Li, M., Liu, S., Lo, K. K., & Zhao, Q. (2022) · Chemistry - An Asian Journal · doi:10.1002/asia.202200429 · Cited by 9
Hu, L., Calucho, E., Fuentes‐Chust, C., Parolo, C., Idili, A., Álvarez-Diduk, R., Rivas, L., & Merkoçi, A. (2022) · Lab on a Chip · doi:10.1039/d2lc00486k · Cited by 9
Jeong, R., & Bulyk, M. L. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100327 · Cited by 11
A myopic perspective on the future of protein diagnostics
Landegren, U. D., Al-Amin, R. A., & Björkesten, J. (2018) · New Biotechnology · doi:10.1016/j.nbt.2018.01.002 · Cited by 9
Qi, W., Davidson, B. A., Nguyen, M. H., Lindstrom, T., Grey, R. J., Burnett, R. A., Aflaki, E., Sidransky, E., & Westbroek, W. (2018) · Biochemical Journal · doi:10.1042/bcj20180708 · Cited by 9
Fast Confirmation of Antibody Identity by MALDI-TOF MS Fingerprints
Tscheuschner, G., Schwaar, T., & Weller, M. G. (2020) · Antibodies · doi:10.3390/antib9020008 · Cited by 10
“On the other side, antibodies are suspected [2] to be a frequent reason for the lack of reproducibility in biomedicine, biochemistry, and bioanalysis [3–6].”
BackgroundNishitani, N., Ohmura, Y., Nagayasu, K., Shibui, N., Kaneko, S., Ohashi, A., Yoshida, T., Yamanaka, A., & Yoshioka, M. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.009 · Cited by 10
“However, our 24 9 CRISPR/Cas9-mediated 5-HT1A receptor knockout strategy will advance the development of 1 selective antibodies in the future and overcome this kind of problems (Baker, 2015).”
BackgroundProximity Ligation Assay as a Tool for Antibody Validation in Human Tissues
Lindskog, C., Backman, M., Zieba, A., Asplund, A., Uhlén, M., Landegren, U. D., & Pontén, F. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420936384 · Cited by 9
Tackling reproducibility: lessons for the proteomics community
Uszkoreit, J., Palmblad, M., & Schwämmle, V. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2320166 · Cited by 9
SysQuan: Repurposing SILAC Mice for the Cost-Effective Absolute Quantitation of the Human Proteome
Mohammed, Y., Richard, V. R., Madlangsakay, M. I. R., Lao, Y., Spicer, V., Popp, R., Gaither, C., Henneken, L., Kleinekofort, W., Zahedi, R. P., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100974 · Cited by 8
Nguyen, J. M. H., Zolg, S., Geiss‐Friedlander, R., & Gorrell, M. D. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05719-4 · Cited by 10
“However, due to the very high homology shared between these two proteins, cross-reactivity is an issue for interpreting DPP9 immunostaining, which is part of a wider issue in biology [101, 102].”
Domański, D., Perzanowska, A., Kistowski, M., Wojtas, G., Michalak, A., Krasowski, G., & Dadlez, M. (2016) · Neoplasia · doi:10.1016/j.neo.2016.06.002 · Cited by 8
Alvarenga, L. M., de Moura, J. F., & Billiald, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63660-7.00005-x · Cited by 10
How can we use proteomics to learn more about platelets?
Aslan, J. E. (2023) · Platelets · doi:10.1080/09537104.2023.2217932 · Cited by 8
“37 Moreover, many proteomics scientists are not experienced in carrying out and interpreting black box assays from commercial sources.”
BackgroundSelective Reaction Monitoring for Quantitation of Cellular Proteins
Faça, V. M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6730-8_18 · Cited by 8
Yang, J., Qi, L., Chiang, H.-C., Yuan, B., Li, R., & Hu, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63115 · Cited by 8
“A lack of standardized guidelines for determining the specificity and reproducibility of antibodies has caused controversies, generation of dubious data and huge amounts of wasted money [3, 59].”
BackgroundPuah, W. C., & Wasser, M. (2015) · Methods · doi:10.1016/j.ymeth.2015.09.028 · Cited by 8
Multiplexed protein profiling by sequential affinity capture
Ayoglu, B., Birgersson, E., Mezger, A., Nilsson, M. F., Uhlén, M., Nilsson, P., & Schwenk, J. M. (2016) · PROTEOMICS · doi:10.1002/pmic.201500398 · Cited by 8
“We and others have acknowledged that antibody performance is application dependent [13].”
BackgroundErrors in data interpretation from genetic variation of human analytes
Howie, H. L., Delaney, M., Wang, X., Er, L. S., Kapp, L. M., Lebedev, J. N., & Zimring, J. C. (2017) · JCI Insight · doi:10.1172/jci.insight.94532 · Cited by 9
“characterized antibody reagents (both monoclonal and polyclonal) — leading to failure of antibodies to recognize their ascribed targets and cross-reactivity with unanticipated targets — has been identified as a major problem in the generation of misinterpreted data (1).”
BackgroundChallenges in Developing a Biochip for Intact Histamine Using Commercial Antibodies
Mattsson, L., Doppler, S., & Preininger, C. (2017) · Chemosensors · doi:10.3390/chemosensors5040033 · Cited by 8
Logical Experimental Design and Execution in the Biomedical Sciences
Holder, D., & Marino, M. J. (2017) · Current Protocols in Pharmacology · doi:10.1002/cpph.20 · Cited by 9
“For antibodies (Uhlen et al., 2016), it is tempting to trust that the antibody ordered from the vendor is what was promised; however, some estimates suggest that as much as 50% of available antibodies are not suitable for their intended use (Baker, 2015).”
BackgroundAdipophilin and perilipin 3 positively correlate with total lipid content in human breast milk
Pavlová, T., Spáčil, Z., Vidová, V., Zlámal, F., Čechová, E., Hodická, Z., & Vašků, J. B. (2020) · Scientific Reports · doi:10.1038/s41598-019-57241-w · Cited by 11
Zhang, L., Wang, S., Yang, Z., Hoshika, S., Xie, S., Li, J., Chen, X., Wan, S., Li, L., Benner, S. A., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201909691 · Cited by 8
Increasing the use of animal-free recombinant antibodies
Groff, K. (2020) · ALTEX · doi:10.14573/altex.2001071 · Cited by 8
“Lack of reproducibility in biomedical research has reached crisis proportions, and antibodies from animal sources are one of the largest contributors (Baker, 2015; Bradbury and Plückthun, 2015; Berglund et al., 2008).”
BackgroundCai, G., Zhang, H., Zhu, R., Zou, Y., & Jia, Q. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118499 · Cited by 8
Technologies to measure and modulate protein subcellular localization
Leineweber, W. D., Tei, R., Mäkiniemi, A., Ting, A. Y., & Lundberg, E. K. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-00957-1 · Cited by 10
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.